Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- "Novartis Land" the Latest Entry in Weird Drug-Based Video Game Trend
- Teva might want to ask Novartis where the latter got its idea for "Novartis Land," the HR video game that Novartis employees are asked to play in order to teach them about ethics. Novartis Land bears a strong resemblance to Teva's game, "Biologicsland." BNET readers will remember...
- Blog posts 2009-03-23
Additional Resources
- NOVARTIS.
- NOVARTIS AG's US affiliate Novartis Seeds and Land O'Lakes Inc., have formed a joint venture to develop specialty corn hybrids for the food and feed markets. Under the agreement, Novartis will purchase a 50 percent interest in Wilson Seeds Inc., an...
- Research articles 1998-10-26
- Novartis Corn JV ...
- Novartis Seeds and food producer Land O'Lakes Minneapolis have formed a jv to genetically engineer specialty corn hydrids for the food and feed markets. It is Novartis's first foray into enhancing the quality or processability of grains. The jv will engineer white corn germplasm from Land...
- Research articles 1998-10-28
- Novartis, Boehringer Start Using Twitter Accounts
- AstraZeneca, Novartis, Vertex Pharmaceuticals and Boehringer Ingelheim have started experimenting with Twitter with varying degrees of enthusiasm, reports Pharmaceutical Executive. Drug companies have so far looked at social media with a mixture of fear and loathing. They believe perhaps wrongly that giving consumers more opportunities to talk...
- Blog posts 2009-02-18
- Pharma Roundup: Roche's DTC Regrets, Novartis and Mylan, and More
- Roche CEO: DTC ads industry's "worst decision." Novartis and Mylan reach patent deal. Trouble in Biotech-land. AmerisourceBergen and its thrifty CEO. by John Maas
- Blog posts 2008-12-02
- DotW: Same As The Old Boss
- Whiners, do-gooders and underdogs, go back to bed. Make yourselves some herbal tea. Go write in your journal or do a little scrapbooking. Maybe you'll feel better.This was not your week, in which we saw nothing less than the restoration of the natural order of the universe. Here's to the...
- News items 2009-10-23
- The 10 Weirdest Drug Stories of the Month
- It's time again for BNET's roundup of the news that was too strange for our regular programming but too interesting to be ignored. Here are the 10 weirdest drug stories of November 2008: French Researchers Working Hard to Take the Fun Out of Pot In France,...
- Blog posts 2008-11-28
- Alexandria Real Estate Equities, Inc. Q2 2009 Earnings Call Transcript
- Question-and-Answer SessionOperator Thank you. Operator instructions. And we will take our first question with Will Marks [ph] from JMP Securities. Please go ahead Will Marks – JMP Securities Hello Joel, hello Dean. Joel Marcus Good afternoon. Will Marks – JMP Securities Good afternoon. I wanted to dig a little...
- Earnings calls 2009-08-08
- Pass the Rolaids Please - GlaxoSmithKline Bid Nears $16 Billion for Pfizer's Consumer Care Division, an Industrial Info News Alert
- SUGAR LAND, Texas -- Reported by Annette Kreuger, Industrial Info Resources, Incorporated (Sugar Land, Texas). While industry giant Pfizer mulls over options regarding its Consumer Care Division, the list of those companies eager to purchase the nearly $4 billion per year unit reads like a who's who of big pharma....
- Research articles 2006-06-07
- Generics Giant Sandoz Completes $10 Million Expansion in North Carolina, an Industrial Info News Alert
- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- Dovetailing nicely with the continuing demand for generic drug products, Sandoz has completed a $10 million expansion at its Wilson, North Carolina, Center of Excellence site. The project added 30,000 square feet to the 170,000-square-foot facility. Sandoz is the...
- Research articles 2007-12-28
- Amgen May Have a Winner on Its Hands
- Ryan Barnes submits: Shares of Amgen (Nasdaq: AMGN) are soaring following the news that a Phase III trial of the company’s Denosumab drug for osteoporosis showed superior effects in treating adverse bone reactions in patients with advanced forms of breast cancer. In the trial summary data released after Tuesday’s close,...
- External links 2009-07-09
- AZ looks to auto plants for efficiency gurus
- Years ago, Japanese car manufacturers turned to management gurus to make their plants more efficient. Now, AstraZeneca is hiring automotive gurus to apply their efficiencies to drug production, the Financial Times reports. It's yet another example of how pharma is borrowing from other industries in an effort to cut costs...
- News items 2009-10-26
- << Previous
- page 1 of 1
- Next >>
